Hangzhou Minsheng Healthcare Co Ltd (SHE:301507) — Market Cap & Net Worth
Market Cap & Net Worth: Hangzhou Minsheng Healthcare Co Ltd (301507)
Hangzhou Minsheng Healthcare Co Ltd (SHE:301507) has a market capitalization of $632.88 Million (CN¥4.33 Billion) as of June 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #11234 globally and #3200 in its home market, demonstrating a -1.14% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hangzhou Minsheng Healthcare Co Ltd's stock price CN¥12.13 by its total outstanding shares 356554330 (356.55 Million). Review Hangzhou Minsheng Healthcare Co Ltd balance sheet liabilities to assess the company's total debt and financial obligations.
Hangzhou Minsheng Healthcare Co Ltd Market Cap History: 2023 to 2026
Hangzhou Minsheng Healthcare Co Ltd's market capitalization history from 2023 to 2026. Data shows change from $853.72 Million to $632.88 Million (-29.82% CAGR).
Hangzhou Minsheng Healthcare Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hangzhou Minsheng Healthcare Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.03x
Hangzhou Minsheng Healthcare Co Ltd's market cap is 1.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.75x
Hangzhou Minsheng Healthcare Co Ltd's market cap is 6.75 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $853.72 Million | $581.73 Million | $85.63 Million | 1.47x | 9.97x |
| 2024 | $662.10 Million | $641.25 Million | $91.83 Million | 1.03x | 7.21x |
| 2025 | $801.41 Million | $781.63 Million | $118.79 Million | 1.03x | 6.75x |
Competitor Companies of 301507 by Market Capitalization
Companies near Hangzhou Minsheng Healthcare Co Ltd in the global market cap rankings as of June 19, 2026.
Key companies related to Hangzhou Minsheng Healthcare Co Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $936.50 Billion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #26 globally with a market cap of $564.26 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #41 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $936.50 Billion | $1112.00 |
| #17 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #26 | Johnson & Johnson | NYSE:JNJ | $564.26 Billion | $234.20 |
| #41 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $221.23 |
Hangzhou Minsheng Healthcare Co Ltd Historical Marketcap From 2023 to 2026
Between 2023 and today, Hangzhou Minsheng Healthcare Co Ltd's market cap moved from $853.72 Million to $ 632.88 Million, with a yearly change of -29.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥632.88 Million | -21.03% |
| 2025 | CN¥801.41 Million | +21.04% |
| 2024 | CN¥662.10 Million | -22.45% |
| 2023 | CN¥853.72 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Hangzhou Minsheng Healthcare Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $632.88 Million USD |
| MoneyControl | $632.88 Million USD |
| MarketWatch | $632.88 Million USD |
| marketcap.company | $632.88 Million USD |
| Reuters | $632.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hangzhou Minsheng Healthcare Co Ltd
Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and health foods in China. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also provides multivitamin,… Read more